Radioligand binding assays and their analysis

Methods in Molecular Biology

Volumn 897, Issue , 2012, Pages 31-77

  Maguire, Janet J ^a   Kuc, Rhoda E ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apelin; Endothelin; Equilibrium dissociation constant; Ghrelin; Hill slope; Image analysis; Knockout mouse; Motilin; Neuropeptide W; Orphan receptor; Quantitative autoradiography; Urocortin II III; Urotensin II

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RADIOLIGAND; LIGAND;

ARTICLE; AUTORADIOGRAPHY; BINDING ASSAY; DISSOCIATION; HUMAN; IMAGE ANALYSIS; LIGAND BINDING; MEASUREMENT; PRIORITY JOURNAL; RADIOASSAY; RECEPTOR DENSITY; ANIMAL; BINDING COMPETITION; COMPUTER GRAPHICS; COMPUTER PROGRAM; DISEASES; DRUG ANTAGONISM; DRUG POTENTIATION; IMAGE PROCESSING; KINETICS; METABOLISM; METHODOLOGY; MOUSE; PROTEIN BINDING; RAT;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; COMPUTER GRAPHICS; DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; LIGANDS; MICE; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RECEPTORS, G-PROTEIN-COUPLED; SOFTWARE;

EID: 84867300970     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-909-9_3     Document Type: Article

References (64)

1. Paton WD, Rang HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetyl-choline receptors. Proc R Soc Lond B 163: 1-44
2. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ (2005) International union of pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279-288
3. Ozawa A, Lindberg I, Roth B, Kroeze WK (2010) Deorphanization of novel peptides and their receptors. AAPS J 12:378-384
4. Wise A, Jupe SC, Rees S (2004) The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol 44: 43-66
5. Katugampola S, Davenport AP (2003) Emerging roles for orphan G protein-coupled receptors in the cardiovascular system. Trends Pharmacol Sci 24:30-35
6. Davenport AP (2003) Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Curr Opin Pharmacol 3:127-134
7. Davenport AP, Macphee CH (2003) Translating the human genome: renaissance of cardiovascular receptor pharmacology. Curr Opin Pharmacol 3:111-113
8. Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman OP, Dunbar DR, Greenhill SD, Hale VA, Sharman JL, Bonner TI, Catterall WA, Davenport AP, Delagrange P, Dollery CT, Foord SM, Gutman GA, Laudet V, Neubig RR, Ohlstein EH, Olsen RW, Peters J, Pin JP, Ruffolo RR, Searls DB, Wright MW, Spedding M (2009) IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res 37:D680-D685
9. Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horre K, Vanbrabant M, Coun F, Baekelandt V, Delacourte A, Fischer DF, Pollet D, De Strooper B, Merchiers P (2009) The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 323:946-951
10. Lappano R, Maggiolini M (2011) G protein-coupled receptors: novel targets for drug discovery in cancer. Nat Rev Drug Discov 10:47-60
11. Jones K, Maguire J, Davenport A (2011) Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol 162:1453-1469
12. Monastyrskaia K, Lundstrom K, Plahl D, Acuna G, Schweitzer C, Malherbe P, Mutel V (1999) Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monoso-dium glutamate taste transduction. Br J Pharmacol 128:1027-1034
13. Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, An SS, Sham JS, Liggett SB (2010) Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 16:1299-1304
14. Birdsall NJ (2010) Class A GPCR heterodim-ers: evidence from binding studies. Trends Pharmacol Sci 31:499-508
15. El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M (2005) Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67:460-469
16. Dong M, Gao F, Pinon DI, Miller LJ (2008) Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors. Mol Endocrinol 22:1489-1499
17. Urwyler S (2011) Allosteric modulation of family C G protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol Rev 63:59-126
18. Schulte G (2010) International union of basic and clinical pharmacology. LXXX. The class Frizzled receptors. Pharmacol Rev 62:632-667
19. Davenport AP, O'Reilly G, Molenaar P, Maguire JJ, Kuc RE, Sharkey A et al (1993) Human endothelin receptors characterised using reverse transcriptase-polymerase chain reaction, in situ hybridization and sub-type selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol 22(S8):22-25
20. Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton P et al (1993) Characterization and localization of endothelin receptor sub-types in the human atrio-ventricu-lar conducting system and myocardium. Circ Res 72:526-538
21. Davenport AP, O'Reilly G, Kuc RE (1995) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br J Pharmacol 114:1110-1116
22. Katugampola SD, Pallikaros Z, Davenport AP (2001) [125I-His9]-ghrelin, a novel radioli-gand for localizing ghs orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br J Pharmacol 134: 143-149
23. Davenport AP (2002) International union of pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226
24. Davenport AP, Maguire JJ (2006) Endothelin. Handb Exp Pharmacol 176:295-329
25. Vachiery JL, Davenport A (2009) The endothe-lin system in pulmonary and renal vasculopa-thy: les liaisons dangereuses. Eur Respir Rev 18:260-271
26. Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Berryman K, Doherty AM (1994) [125I]-PD15242, a selective radioligand for human ETA receptors. Br J Pharmacol 111:4-6
27. Davenport AP, Kuc RE, Hoskins SL, Karet FE, Fitzgerald F (1994) [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localises to renal vascu-lature. Br J Pharmacol 113:1303-1310
28. Peter MG, Davenport AP (1995) Selectivity of [125I]-PD151242 for the human, rat and porcine endothelin ETA receptors in the heart. Br J Pharmacol 114:297-302
29. Hulme EC, Trevethick MA (2010) Ligand binding assays at equilibrium: validation and interpretation. Br J Pharmacol 161:1219-1237
30. Hulme E (1992) Receptor-ligand interactions. IRL, Oxford, UK
31. de Jong LA, Uges DR, Franke JP, Bischoff R (2005) Receptor-ligand binding assays: technologies and applications. J Chromatogr B 829:1-25
32. Carter CM, Leighton-Davies JR, Charlton SJ (2007) Miniaturized receptor binding assays: complications arising from ligand depletion. J Biomol Screen 12:255-266
33. Vauquelin G, Charlton SJ (2010) Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br J Pharmacol 161:488-508
34. Kenakin T (2004) Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25: 186-192
35. Kenakin T (1993) Pharmacologic analysis of drug-receptor interactions. Raven, New York, NY
36. Kenakin T, Miller LJ (2010) Seven transmem-brane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 62:265-304
37. Neubig RR, Spedding M, Kenakin T, Christopoulos A (2003) International Union of Pharmacology Committee on receptor nomenclature and drug classi fication. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 11(55): 597-606
38. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP (2010) Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 160:1785-1795
39. Molenaar P, Kuc RE, Davenport AP (1992) Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1, 3, 11, 15]ET-1 in human heart. Br J Pharmacol 107:637-639
40. Katugampola SD, Maguire JJ, Matthewson SR, Davenport AP (2001) [(125)I]-(Pyr(1)) Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132:1255-1260
41. Wiley KE, Davenport AP (2004) CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br J Pharmacol 143:508-514
42. Kleinz MJ, Maguire JJ, Skepper JN, Davenport AP (2006) Functional and immunocytochemi-cal evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 69:227-235
43. Kirby HR, Maguire JJ, Colledge WH, Davenport AP (2010) International union of basic and clinical pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution and function. Pharmacol Rev 62:565-578
44. Mead EJ, Maguire JJ, Kuc RE, Davenport AP (2007) Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 151:1143-1153
45. Mead EJ, Maguire JJ, Kuc RE, Davenport AP (2007) Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology 148:140-147
46. Singh G, Davenport AP (2006) Neuropeptide B and W: neurotransmitters in an emerging G protein-coupled receptor system. Br J Pharmacol 148:1033-1041
47. Singh G, Maguire JJ, Kuc RE, Fidock M, Davenport AP (2004) Identification and cellular localisation of NPW1 (GPR7) receptors for the novel neuropeptide W-23 by [125I]-NPW radioligand binding and immunocytochemis-try. Brain Res 1017:222-226
48. Mitchell JD, Maguire JJ, Davenport AP (2009) Emerging pharmacology and physiology of neu-romedin U and the structurally related peptide neuromedin S. Br J Pharmacol 158:87-103
49. Mitchell JD, Maguire JJ, Kuc RE, Davenport AP (2009) Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. Cardiovasc Res 81:353-361
50. Maguire JJ, Kuc RE, Davenport AP (2000) Orphan-receptor ligand human urotensin ii: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-446
51. Maguire JJ, Kuc RE, Kleinz MJ, Davenport AP (2008) Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Peptides 29:735-742
52. Maguire JJ, Parker WA, Foord SM, Bonner TI, Neubig RR, Davenport AP (2009) International union of pharmacology. LXXII. Recommendations for trace amine receptor nomenclature. Pharmacol Rev 61:1-8
53. Kutzler MA, Molnar J, Schlafer DH, Kuc RE, Davenport AP, Nathanielsz PW (2003) Maternal dexamethasone increases endothe-lin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta 24:392-402
54. Telemaque-Potts S, Kuc RE, Yanagisawa M, Davenport AP (2000) Tissue-speci fic modulation of endothelin receptors in a rat model of hypertension. J Cardiovasc Pharmacol 36(S1): 122-123
55. Telemaque-Potts S, Kuc RE, Maguire JJ, Ohlstein E, Yanagisawa M, Davenport AP (2002) Elevated systemic levels of endothelin-1 and blood pressure correlate with blunted constrictor responses and downregulation of endothelin A, but not endothelin B, receptors in an animal model of hypertension. Clin Sci (Lond) 103(Suppl 48):357S-362S
56. Davenport AP, Kuc RE (2004) Down-regulation of ETA receptors in ETB receptor-deficient mice. J Cardiovasc Pharmacol 44(Suppl 1): S276-S278
57. Kuc RE, Davenport AP (2000) Endothelin-A-receptors in human aorta and pulmonary arteries are down regulated in patients with cardiovascular disease: an adaptive response to increased levels of ET-1? J Cardiovasc Pharmacol 36(S1):377-379
58. Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, Gulliver-Sloan FH, Maguire JJ, Davenport AP, Kotelevtsev YV, Webb DJ (2010) Endothelial cell-speci fic ETB receptor knockout: autoradiographic and his-tological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88:644-651
59. Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, Webb DJ, Kotelevtsev YV (2006) Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48:286-293
60. Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
61. McPherson GA (1985) Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J Pharmacol Methods 14:213-228
62. Davenport AP, Hall MD (1988) Comparison between brain paste and polymer standards for quantitative receptor autoradiography. J Neurosci Methods 25:75-82
63. Pitkin SL, Maguire JJ, Bonner TI, Davenport AP (2010) International union of basic and clinical pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology and function. Pharmacol Rev 62:331-342
64. Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP (2009) [Pyr1]apelin-13 identi fied as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 54:598-604